{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-044627","form_type":"8-K","ticker":"ARVN","cik":"0001655759","company_name":"ARVINAS, INC.","filed_at":"2026-06-22T20:10:16+00:00","discovered_at":"2026-06-22T20:11:00.298967+00:00","generated_at":"2026-06-22T20:11:28.807574+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Arvinas CMO Noah Berkowitz to depart July 3, 2026; severance includes accelerated RSU vesting","bullets":["Dr. Berkowitz will leave as CMO effective July 3, 2026, to pursue other opportunities.","Company has begun a search for a new chief medical officer.","Separation agreement provides 9 months base salary, health coverage, and accelerated vesting of RSUs vesting on or before May 9, 2027.","All other unvested RSUs will be forfeited."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-044627","json":"https://secwatch.observer/filing/0001628280-26-044627.json","markdown":"https://secwatch.observer/filing/0001628280-26-044627.md","text":"https://secwatch.observer/filing/0001628280-26-044627.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026044627/0001628280-26-044627-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026044627/arvn-20260622.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T20:11:28.807574+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a4e232a64f","claim":"Noah Berkowitz departed as chief medical officer at ARVINAS, INC..","evidence_excerpt":"On June 22, 2026, Arvinas, Inc., a Delaware corporation (the “Company”), and Noah Berkowitz, M.D., Ph.D., the Company’s chief medical officer, agreed that Dr. Berkowitz would depart from his employment with the Company, effective July 3, 2026 (the “Departure”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026044627/0001628280-26-044627-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"chief medical officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}